microdosing glp-1 peptides GLP-1: A Science-Backed Path to Longevity & Wellness Microdosing GLP-1s: Reduce Inflammation, Support

We're Here for You

Currently, GLP-1R agonists are mainly targeted on the endogenous GLP-1R signaling system, which causes GLP-1R agonists to have many pharmacodynamic characteristics like GLP-1

These can include disorders such as VLCAD or MCAD, or disorders related to problems in the carnitine cycle in the mitochondria due to defective enzymes

Typical daily range: 2.55 mg once or twice daily (subcutaneous)

Consult a qualified healthcare professional before making any decision about your own health

"They eventually stop taking the medication, or their insurance stops covering it, they'll change a job [so] it's no longer covered." Cook said not everyone will be able to taper off the medication, so some people will likely end up taking it indefinitely